Unlike anti-Ro(SS-A) antibody positive subacute cutaneous lupus erythematosus (SCLE) patients, anti-Ro(SS-A) antibody positive lupus patients with Sjögren's syndrome (SS/LE) appear to have a more guarded prognosis. Our studies indicate these SS/LE patients have an increased frequency of pulmonary, neurological, and renal disease compared to SCLE patients.
Maddison PJ, Mogavero H., Provost TT, Reichlin M.The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol1979; 6: 189-195.
2.
Scopelitis E. , Perez M., Biundo JJAnti-SS-A(Ro) antibody: A connective tissue disease marker. J Rheumatol1985; 12: 1105-1108.
3.
Simmons-O'Brien E. et al. One hundred anti-Ro(SS-A) antibody positive patients: A 10 year follow-up. Medicine1995; 74: 109-130.
4.
Ahearn JN et al. Interrelationship of HLA-DR MB and MT phonotypes. Autoantibody expression and clinical features in systemic lupus erythematosus. Arth Rheum1982; 25: 1031-1040.
5.
Alvarellos A. et al. Relationship of HLA-DR, and MT antigens to autoantibody expression in SLE. Arth Rheum1983; 26: 1533—1535.
6.
Hochberg MC et al. Syustemic lupus erythematosus: A review of clinicolaboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine1985; 64: 285-295.
7.
Watson RM et al. Neonatal lupus erythematosus: Clinical, serological and immunogenetic study with review of the literature. Medicine1984; 63: 362-378.
8.
Provost TT, Watson RMAnti-Ro(SS-A), HLA-DR3 positive females: The interrelationship betwen some ANA negative, SS, SCLE, NLE mothers and SS/LE overlap female patients. J Invest Dermatol1993; 100: 14S-20S.
9.
Reveille JD et al. Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro(SS-A)/La(SS-B) autoantibody responses. J Immunol1991; 146: 3871-3876.
10.
Sontheimer RD, Thomas JR, Gilliam JDSubacute cutaneous lupus erythematosus: A cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol1979 ; 115: 1409-1415.
11.
Sontheimer RDSubacute cutaneous lupus erythematosus: A decade's perspective. Med Clinics North Am1989; 73: 1073-1090.
12.
Catoggio LR et al. Systemic lupus erythematosus in the elderly: Clinical and serologic characteristics. J Rheumatol1984; 11: 175-181.
Provost TT et al. The relationship between anti-Ro(SS-A) antibody positive Sjögren's syndrome and anti-Ro(SS-A) antibody positive lupus erythematosus. Arch Dermatol1988; 124: 63-71.
15.
Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arth Rheum1982; 25: 1271-1277.
16.
Drosos AA et al. Subacute cutaneous lupus erythematosus in Greece. A clinical, serologic and genetic study. Ann Med Interne1990; 141: 421-424.
17.
Herrero C. et al. Subacute cutaneous lupus erythematosus. Clinical pathologic findings in 13 cases. J Am Acad Dermatol1988 ; 19: 1057-1062.
18.
Johansson-Stephansson E. et al. Subacute cutaneous lupus erythematosus. Clinical, histological, and immunologic findings. J Am Acad Dermatol1982 ; 6: 73-83.
Alexander EL et al. Sjögren's syndrome: Association of anti-Ro antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity . Ann Int Med1983; 98: 155-159.
29.
Harley JB et al. Anti-Ro(SS-A) and anti-La(SS-B) in Sjöogren's syndrome. Arth Rheum1986; 29: 196-206.
30.
Senecal JL, Chartier S., Rothfield N.Hypergammaglobulinemic purpura in systemic autoimmune diseases: Predictive value of anti-Ro(SS-A) ad anti-La(SS-B) antibodies and treatment with Indomethacin and hydroxychloroquine. J Rheumatol1995; 22: 868-875.
31.
Targott INHumoral immunity in polymyositis/dermatomyositis. J Invest Dermatol1993; 100: 116S-123S.
32.
Kraus A. et al. Myositis in primary Sjögren's syndrome. Report of 3 cases. J Rheumatol1994; 21: 649-653.
33.
Boire G. et al. Rheumatoid arthritis: Anti-Ro antibodies define a non-HLA-DR4 associated clincoserological cluster. J Rheumatol1993; 20: 1654-1660.
34.
Alexander GE , Provost TT, Stevens MB, Alexander E.Sjögren's syndrome: Central nervous system manifestations. Neurology1981; 31: 1391-1396.Heitahayu A., Yli-Keittula U., Hakkinea V., Frey H.Nervous system manifestations in Sjögren's syndrome. Acta Neurol Scand1990; 81: 144-152.
35.
Kaltrieder HB, Talal N.The neuropathy of Sjögren's syndrome. Trigeminal nerve involvement. Ann Int Med1969; 70: 751-762.
36.
Malinow KL . Neuropsychiatric dysfuntion in primary Sjögren 's syndrome. Ann Int Med1985; 103: 344—349.
37.
Malinow K. et al. Subacute sensory neuropathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome. Ann Neurol1986; 20: 535-537.
38.
Maddison PJ , Reichlin M.Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus. Arth Rheum1979; 22: 858-863.
